MedTrace Logo

Predictive MRI Metrics for Tumor Aggressiveness in Papillary Thyroid Cancer

NCT02178345 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 123

Last updated 2021-12-08

No results posted yet for this study

Summary

Magnetic resonance imaging (MRI) is a diagnostic technique that takes pictures of organs of the body. It uses magnetic fields and radio waves that cannot be felt. Perfusion MRI uses faster imaging. It also includes a contrast material that is given by vein. This makes specific organs, blood vessels, or tumors easier to see. Diffusion MRI lets us measure the motion of water in the tumor.

Perfusion and diffusion MRI give extra information which is not available with the regular MRI. A regular MRI only shows pictures of the tumor. Thyroid MRI scans are not part of the current standard of care. The purpose of this study is to see if new MRI methods can give us more information about the tumor.

Conditions

  • Papillary Thyroid Cancer

Interventions

PROCEDURE

diffusion weighted (DW) MRI

PROCEDURE

dynamic contrast agent (DCE) MRI

Sponsors & Collaborators

Principal Investigators

  • Amita Dave, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-24
Primary Completion
2021-12-03
Completion
2021-12-03

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02178345 on ClinicalTrials.gov